<DOC>
	<DOC>NCT00314145</DOC>
	<brief_summary>The purpose of this study is to determine non-inferiority in seroconversion and to compare the safety and tolerability between ChimeriVaxTM-JE and JE-VAX to the respective homologous virus strain after completion of vaccination course.</brief_summary>
	<brief_title>A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects aged 18 or above Subjects in good general health. Females must have negative pregnancy test and be using adequate form of contraception History of vaccination/infection with JE or Yellow fever or other flaviviruses History of residence/travel to flavivirus endemic regions History of anaphylaxis/serious adverse reactions Administration of vaccine within 30 days of study or during treatment period Clinically significant physical exam/medical history/lab abnormalities Pregnancy Excessive alcohol/drug abuse Hypersensitivity to constituents of JEVAX® Blood transfusion/treatment with blood product within 6months of study and during study treatment period Known/suspected immunodeficiency Compromised blood brain barrier Employees of Clinical Research Organization (CRO)/study site staff Any other condition which would exclude subject.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>